Reply

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3645-3646

  Bartels, Christie M ^a   Everett, Christine ^a   McBride, Patrick ^a   Smith, Maureen ^a   Kind, Amy J H ^a   Mell, Matthew ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; HUMAN; INFLAMMATION; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK MANAGEMENT;

EID: 80155211526     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30587     Document Type: Letter

References (6)

1. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011; 70: 482-7.
2. Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003; 42: 1933-40. (Pubitemid 37485568)
3. Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KF, et al. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 2005; 33: 1610-5. (Pubitemid 40980620)
4. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE,. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 2004; 50: 3450-7. (Pubitemid 39488669)
5. Semb AG, Kvien TK, Aastveit AH, Jungner I, Pedersen TR, Walldius G, et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality Risk (AMORIS) Study. Ann Rheum Dis 2010; 69: 1996-2001.
6. National Guideline Clearinghouse. Screening for lipid disorders in adults. URL:.